Japan's Pharma and Medical Devices Amendment Demands Compliance
Pharmaceutical and biotech companies face new structural challenges and considerations for entry into the Japanese market. These challenges could result in a lack of bandwidth that hampers corporate growth in Japan.
Source: natlawreview.com